Seelos Therapeutics, Inc. Announces $4.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
Stock Information for Clarus Corporation
Loading
Please wait while we load your information from QuoteMedia.